Meta description: A regulatory oriented review of a ClinicalTrials.gov record on auricular point sticking for IVF that highlights psychological well being sleep and treatment outcomes.
As of February 15, 2026 a trial record details auricular point sticking as an adjunct to conventional artificial cycle therapy. The sponsor is Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University. The study targets infertility in women along with anxiety sleep disturbances and depression. Enrollment is by invitation and the registry number is NCT07409792 with a public link in the source text.
What is auricular point sticking and why study it in IVF?
Auricular point sticking is a traditional ear based stimulation approach. In this trial it is described as an additional intervention alongside standard IVF cycle therapy. The therapy is presented as a non drug option to be used in conjunction with assisted reproductive techniques. The listed conditions include infertility in women, anxiety, dyssomnias and depression, indicating a focus on psychological and sleep related symptoms in the IVF population.
What is the intervention?
The intervention is named auricular point sticking therapy. It is described as the other type of intervention in the study design. The approach relies on ear based stimulation rather than a pharmacologic agent and is intended to be used with conventional therapy under clinical supervision. The description implies attention to safety and compatibility with existing IVF procedures as would be expected in a regulated trial.
What conditions are addressed in the study?
The study lists infertility in women, anxiety, dyssomnias and depression as conditions of interest. It also references assisted reproductive techniques. Together these elements suggest outcomes related to mental health and sleep alongside traditional fertility endpoints may be monitored.
How is this work framed in regulatory terms?
What is the intended purpose as described by the sponsor?
The sponsor describes auricular point sticking as a therapeutic option to support IVF care. It is described as an adjunct to conventional artificial cycle therapy. This framing aligns with a regulatory style that treats experiments with device based therapy as requiring safety and performance evaluation alongside clinical endpoints. The precise regulatory status of the intervention remains to be determined by authorities.
What is the safety and performance posture?
Safety concerns are acknowledged in the trial design. The description does not claim efficacy and emphasizes standard clinical care. Investigators are expected to monitor adverse events in line with trial protocols and applicable regulations. The information presented is a registry record and not a final device clearance decision.
Who is involved and how is the study designed?
Who is sponsoring?
The sponsor is Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University. The institution is based in China and aligns traditional medicine practices with contemporary clinical research frameworks.
What is the trial status and enrollment method?
Enrollment is by invitation. This indicates selective inclusion criteria and limited enrollment at this stage. The entry in ClinicalTrials.gov provides a registry number NCT07409792 and links to study details. The trial uses auricular point sticking therapy together with conventional therapy as described in the source.
Where can readers verify details?
Readers can verify details on ClinicalTrials.gov using the provided link. The full registry entry is accessible at https://clinicaltrials.gov/study/NCT07409792?term=medical+device
What are potential implications for patients and clinicians?
What outcomes are sought?
The study aims to evaluate psychological well being, sleep and IVF related outcomes. The description does not assert efficacy. If safety is acceptable and signals of benefit emerge, these findings could shape future research and regulatory discussions regarding device based adjuncts in IVF care.
FAQ
- 1. What is auricular point sticking?
Auricular point sticking is an ear based stimulation therapy described in the trial as an adjunct to IVF care. - 2. Who is sponsoring the study?
The sponsor is Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University in China. - 3. How can I verify details?
Details are available on ClinicalTrials.gov at https://clinicaltrials.gov/study/NCT07409792?term=medical+device
Conclusion
In summary the record outlines a trial of auricular point sticking as an adjunct to IVF care. The information supports regulatory teams to monitor trial design and safety data. Clinicians and sponsors may consider how such non drug interventions align with standard care and regulatory expectations.
Disclaimer
This article is for professional use only. It does not constitute legal advice or guidance. It is not a regulatory determination. For official guidance consult regulatory bodies and the registry entry.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07409792?term=medical+device